MYT1 and pulmonary arterial hypertension: Likewise, using siRNAs targeting Wee1, Myt1, CDC25A, CDC25B, or CDC25C in PAH HPASMC also significantly reduced CDC2 expression compared to control siRNA (Figure 5B).